243 filings
Page 5 of 13
8-K
t8wk 1cqd24
26 Jun 20
Other Events
12:00am
8-K
8adp g821g6cepcgdy
11 Jun 20
CytoSorbents Awarded $2,897,172 Phase III STTR Contract to Advance HemoDefend-BGA Plasma and Whole Blood Filter to Clinical Trials
4:30pm
8-K
7l8c1t22vxbdps82
4 Jun 20
Submission of Matters to a Vote of Security Holders
12:00am
8-K
3hz3dz lh5
12 May 20
CytoSorb® is E.U. Approved to Remove Rivaroxaban, a Leading Factor Xa Inhibitor and Novel Oral Anticoagulant, During On-Pump Cardiothoracic Surgery
4:30pm
8-K
u6skx0f6c4r
5 May 20
CytoSorbents Reports First Quarter 2020 Financial and Operational Results
5:05pm
8-K
cnln 4f67b11u4lt4
4 May 20
Departure of Directors or Certain Officers
5:27pm
8-K
i590lloc7p20zgd3k
30 Apr 20
CytoSorbents to Report Q1 2020 Operating and Financial Results
4:15pm
8-K
1h6uhf3
30 Apr 20
CytoSorbents Receives $1.1 Million in Non-Dilutive Funding from the New Jersey Business Tax Certificate Transfer Program
4:15pm
8-K
q2a63 xhcl3l
27 Apr 20
Cytosorbents Appoints DR. Efthymios N. Deliargyris, M.D., As Chief Medical Officer
5:05pm
8-K
0yt40deyobh635
20 Apr 20
Entry into a Material Definitive Agreement
5:18pm
8-K
qy6mtu
20 Apr 20
Other Events
5:14pm
8-K
gb6cy61y
17 Apr 20
New Study Suggests CytoSorb Improves Clinical Outcomes in Pneumonia Patients With Septic Shock and Acute Respiratory Distress Syndrome (ARDS) on ECMO
7:30am
8-K
9lo oahnduxxfzt3m1
16 Apr 20
Other Events
5:25pm
8-K
9lo7lztrk7kz54jeca
5 Mar 20
CytoSorbents Announces 2019 Financial and Operational Results
5:18pm
8-K
taq39znar nfjda
3 Mar 20
Departure of Directors or Certain Officers
5:00pm
8-K
r3glw
14 Jan 20
CytoSorbents Reports Preliminary 2019 Financial Results and Issues Stockholder Letter
4:06pm
8-K
32tsm34 hyvs6axo
2 Jan 20
Amendments to Articles of Incorporation or Bylaws
5:25pm
8-K
6zei0dj
12 Dec 19
Departure of Directors or Certain Officers
4:05pm
8-K
00e yosgj
25 Nov 19
CytoSorbents Changes Contract Research Organizations and Temporarily Pauses Enrollment in REFRESH 2-AKI Study
7:15am
8-K
eivxip qm
6 Nov 19
Departure of Directors or Certain Officers
5:20pm